169 related articles for article (PubMed ID: 19125012)
21. Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer.
Robinson BG; Paz-Ares L; Krebs A; Vasselli J; Haddad R
J Clin Endocrinol Metab; 2010 Jun; 95(6):2664-71. PubMed ID: 20371662
[TBL] [Abstract][Full Text] [Related]
22. [Medullary thyroid cancer, a tumour with many appearances].
Verbeek HH; de Groot JW; Plukker JT; Hofstra RW; Brouwers AH; Kerstens MN; Links TP
Ned Tijdschr Geneeskd; 2010; 154():A1818. PubMed ID: 20858319
[TBL] [Abstract][Full Text] [Related]
23. Medullary thyroid carcinoma: a 20-year experience from a centre in South India.
Finny P; Jacob JJ; Thomas N; Philip J; Rajarathnam S; Oommen R; Nair A; Seshadri MS
ANZ J Surg; 2007 Mar; 77(3):130-4. PubMed ID: 17305985
[TBL] [Abstract][Full Text] [Related]
24. [Medullary cancer of the thyroid].
Modigliani E
Rev Prat; 1996 Dec; 46(19):2303-8. PubMed ID: 8978187
[TBL] [Abstract][Full Text] [Related]
25. New therapeutic approaches to treat medullary thyroid carcinoma.
Schlumberger M; Carlomagno F; Baudin E; Bidart JM; Santoro M
Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):22-32. PubMed ID: 18084343
[TBL] [Abstract][Full Text] [Related]
26. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.
Karges W; Dralle H; Raue F; Mann K; Reiners C; Grussendorf M; Hüfner M; Niederle B; Brabant G;
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):52-8. PubMed ID: 14758572
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and therapeutic aspects in medullary thyroid carcinoma.
Safioleas M; Stamatakos M; Karampali E; Rompoti N; Mouzopoulos G; Lygidakis N
Chirurgia (Bucur); 2006; 101(2):121-6. PubMed ID: 16752676
[TBL] [Abstract][Full Text] [Related]
28. Treatment of recurrent thyroid cancers--is there a light in the horizon?
Rovere RK; Awada A
Curr Opin Oncol; 2008 May; 20(3):245-8. PubMed ID: 18391621
[TBL] [Abstract][Full Text] [Related]
29. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
Krause BJ; Herrmann K; Wieder H; zum Büschenfelde CM
J Nucl Med; 2009 May; 50 Suppl 1():89S-96S. PubMed ID: 19380406
[TBL] [Abstract][Full Text] [Related]
30. Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma.
Messina M; Robinson BG
Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):290-301. PubMed ID: 17315037
[TBL] [Abstract][Full Text] [Related]
31. Management of medullary thyroid carcinoma.
Jiménez C; Hu MI; Gagel RF
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338
[TBL] [Abstract][Full Text] [Related]
32. Medullary thyroid carcinoma: surgical treatment advances.
Dionigi G; Tanda ML; Piantanida E
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):158-62. PubMed ID: 18327036
[TBL] [Abstract][Full Text] [Related]
33. Medical management of persistent or recurrent differentiated thyroid carcinoma.
Jun JY; Manni A
Otolaryngol Clin North Am; 2008 Dec; 41(6):1241-60, xi-xii. PubMed ID: 19040983
[TBL] [Abstract][Full Text] [Related]
34. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
35. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
Schwarz JK; Grigsby PW; Dehdashti F; Delbeke D
J Nucl Med; 2009 May; 50 Suppl 1():64S-73S. PubMed ID: 19380409
[TBL] [Abstract][Full Text] [Related]
36. Medullary thyroid cancer diagnosis: an appraisal.
Trimboli P; Giovanella L; Crescenzi A; Romanelli F; Valabrega S; Spriano G; Cremonini N; Guglielmi R; Papini E
Head Neck; 2014 Aug; 36(8):1216-23. PubMed ID: 23955938
[TBL] [Abstract][Full Text] [Related]
37. FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome.
Karam M; Ata A; Irish K; Feustel PJ; Mottaghy FM; Stroobants SG; Verhoef GE; Chundru S; Douglas-Nikitin V; Oliver Wong CY; Brepoels LM
Nucl Med Commun; 2009 Oct; 30(10):770-8. PubMed ID: 19657307
[TBL] [Abstract][Full Text] [Related]
38. Advances and controversies in the management of medullary thyroid carcinoma.
Maia AL; Wajner SM; Vargas CV
Curr Opin Oncol; 2017 Jan; 29(1):25-32. PubMed ID: 27792051
[TBL] [Abstract][Full Text] [Related]
39. Activity of novel plant extracts against medullary thyroid carcinoma cells.
Rinner B; Siegl V; Pürstner P; Efferth T; Brem B; Greger H; Pfragner R
Anticancer Res; 2004; 24(2A):495-500. PubMed ID: 15152949
[TBL] [Abstract][Full Text] [Related]
40. Teflon laryngeal granuloma presenting as laryngeal cancer on combined positron emission tomography and computed tomography scanning.
Ondik MP; Kang J; Bayerl MG; Bruno M; Goldenberg D
J Laryngol Otol; 2009 May; 123(5):575-8. PubMed ID: 18976510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
